229000.KQ
Price:
$1728
Market Cap:
$40.48B
Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.
Industry
Medical - Specialties
IPO Date
2015-10-27
Stock Exchange
KOE
Ticker
229000.KQ
According to Gencurix, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.96. This represents a change of -31.89% compared to the average of -5.81 of the last 4 quarters.
The mean historical PE Ratio of Gencurix, Inc. over the last ten years is -6.85. The current -3.96 PE Ratio has changed 5.68% with respect to the historical average. Over the past ten years (40 quarters), 229000.KQ's PE Ratio was at its highest in in the September 2020 quarter at 31.79. The PE Ratio was at its lowest in in the June 2020 quarter at -51.45.
Average
-6.85
Median
-5.50
Minimum
-20.68
Maximum
3.31
Discovering the peaks and valleys of Gencurix, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 85.82%
Maximum Annual PE Ratio = 3.31
Minimum Annual Increase = -214.21%
Minimum Annual PE Ratio = -20.68
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.35 | -53.09% |
| 2024 | -7.15 | 85.82% |
| 2023 | -3.85 | 79.44% |
| 2022 | -2.14 | -43.24% |
| 2021 | -3.78 | -214.21% |
| 2020 | 3.31 | -130.31% |
| 2019 | -10.91 | -47.22% |
| 2018 | -20.68 | 80.08% |
| 2017 | -11.48 | 36.17% |
| 2016 | -8.43 | -51.84% |
The current PE Ratio of Gencurix, Inc. (229000.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.78
5-year avg
-4.06
10-year avg
-6.85
Gencurix, Inc.’s PE Ratio is less than Xcell Therapeutics, Inc. (-1.68), greater than Hass (-186.98), greater than IVIM Technology (-15.96), greater than BCWORLD PHARM. Co., Ltd. (-9.93), less than LAMEDITECH Co., Ltd. (-2.21), less than Tdspharm (6.38),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.68 | $21.29B | |
| -186.98 | $39.05B | |
| -15.96 | $42.86B | |
| -9.93 | $30.87B | |
| -2.21 | $25.53B | |
| 6.38 | $32.21B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gencurix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gencurix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Gencurix, Inc.'s PE Ratio?
How is the PE Ratio calculated for Gencurix, Inc. (229000.KQ)?
What is the highest PE Ratio for Gencurix, Inc. (229000.KQ)?
What is the 3-year average PE Ratio for Gencurix, Inc. (229000.KQ)?
What is the 5-year average PE Ratio for Gencurix, Inc. (229000.KQ)?
How does the current PE Ratio for Gencurix, Inc. (229000.KQ) compare to its historical average?